Published in J Bone Miner Res on September 20, 2004
Bisphosphonates and bone fractures in long-term kidney transplant recipients. Transplantation (2008) 0.96
Suppressive effects of 1,4-dihydroxy-2-naphthoic acid administration on bone resorption. Osteoporos Int (2009) 0.89
Medication-induced osteoporosis: screening and treatment strategies. Ther Adv Musculoskelet Dis (2014) 0.87
Elevated incidence of fractures in solid-organ transplant recipients on glucocorticoid-sparing immunosuppressive regimens. J Osteoporos (2011) 0.83
Updated recommendations for the diagnosis and management of osteoporosis: a local perspective. Ann Saudi Med (2011) 0.81
Ibandronate increases cortical bone density in patients with systemic lupus erythematosus on long-term glucocorticoid. Arthritis Res Ther (2010) 0.80
Patients with cirrhosis and ascites have false values of bone density: implications for the diagnosis of osteoporosis. Osteoporos Int (2011) 0.78
Effects of bisphosphonate treatment on bone repair under immunosuppression using cyclosporine A in adult rats. Osteoporos Int (2007) 0.76
Metabolic bone diseases in kidney transplant recipients. World J Nephrol (2012) 0.75
Bisphosphonates routine in prevention of post-transplant osteoporosis? J Bone Miner Res (2005) 0.75
Mineral and bone disorder after kidney transplantation. World J Transplant (2015) 0.75
Osteoporosis in Children with Chronic Illnesses: Diagnosis, Monitoring, and Treatment. Curr Osteoporos Rep (2017) 0.75
Teriparatide or alendronate in glucocorticoid-induced osteoporosis. N Engl J Med (2007) 7.60
Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res (2007) 6.76
High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy. J Clin Oncol (2009) 2.97
Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration study. Arthritis Rheum (2006) 2.82
Microarchitectural deterioration of cortical and trabecular bone: differing effects of denosumab and alendronate. J Bone Miner Res (2010) 2.37
Bone disease in HIV infection: a practical review and recommendations for HIV care providers. Clin Infect Dis (2010) 2.20
The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab (2008) 2.12
High-resolution peripheral quantitative computed tomography can assess microstructural and mechanical properties of human distal tibial bone. J Bone Miner Res (2010) 2.01
Relationship between moderate to severe kidney disease and hip fracture in the United States. J Am Soc Nephrol (2006) 1.91
Abdominal fat is associated with lower bone formation and inferior bone quality in healthy premenopausal women: a transiliac bone biopsy study. J Clin Endocrinol Metab (2013) 1.88
Short-term bone loss in HIV-infected premenopausal women. J Acquir Immune Defic Syndr (2010) 1.87
Differences in bone microarchitecture between postmenopausal Chinese-American and white women. J Bone Miner Res (2011) 1.86
Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW). Bone (2012) 1.79
Abnormal microarchitecture and reduced stiffness at the radius and tibia in postmenopausal women with fractures. J Bone Miner Res (2010) 1.78
Chronic kidney disease and bone fracture: a growing concern. Kidney Int (2008) 1.76
Rapid cortical bone loss in patients with chronic kidney disease. J Bone Miner Res (2013) 1.74
Bone fragility and collagen cross-links. J Bone Miner Res (2004) 1.68
Bone microarchitecture and stiffness in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab (2009) 1.61
Use of FTIR spectroscopic imaging to identify parameters associated with fragility fracture. J Bone Miner Res (2009) 1.54
Bone density, geometry, microstructure, and stiffness: Relationships between peripheral and central skeletal sites assessed by DXA, HR-pQCT, and cQCT in premenopausal women. J Bone Miner Res (2010) 1.50
Pancreas-kidney transplantation is associated with reduced fracture risk compared with kidney-alone transplantation in men with type 1 diabetes. Kidney Int (2013) 1.48
Clenbuterol increases lean muscle mass but not endurance in patients with chronic heart failure. J Heart Lung Transplant (2008) 1.46
Dynamic and structural properties of the skeleton in hypoparathyroidism. J Bone Miner Res (2008) 1.46
Individual trabeculae segmentation (ITS)-based morphological analysis of high-resolution peripheral quantitative computed tomography images detects abnormal trabecular plate and rod microarchitecture in premenopausal women with idiopathic osteoporosis. J Bone Miner Res (2010) 1.46
Association between plasma 25-hydroxyvitamin D and breast cancer risk. Cancer Prev Res (Phila) (2009) 1.44
Dynamics of bone turnover markers in patients with heart failure and following haemodynamic improvement through ventricular assist device implantation. Eur J Heart Fail (2012) 1.43
Guidelines for the treatment of postmenopausal osteoporosis for general practitioners. Aust Fam Physician (2002) 1.42
Prevention of fractures after solid organ transplantation: a meta-analysis. J Clin Endocrinol Metab (2011) 1.41
Individual trabecula segmentation (ITS)-based morphological analyses and microfinite element analysis of HR-pQCT images discriminate postmenopausal fragility fractures independent of DXA measurements. J Bone Miner Res (2012) 1.40
Bone mass and mineral metabolism in HIV+ postmenopausal women. Osteoporos Int (2005) 1.40
Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment. J Clin Endocrinol Metab (2003) 1.38
Growth and skeletal maturation after pediatric cardiac transplantation. Pediatr Transplant (2004) 1.38
Osteonecrosis of the jaw: more research needed. J Bone Miner Res (2006) 1.36
Zoledronic acid prevents bone loss in premenopausal women undergoing adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol (2008) 1.36
PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism. J Bone Miner Res (2011) 1.30
Longterm effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee. J Rheumatol (2006) 1.29
Bone mass and microarchitecture in CKD patients with fracture. J Am Soc Nephrol (2010) 1.26
Benefits and risks of bisphosphonate therapy for osteoporosis. J Clin Endocrinol Metab (2012) 1.24
Individual trabecula segmentation (ITS)-based morphological analysis of microscale images of human tibial trabecular bone at limited spatial resolution. J Bone Miner Res (2011) 1.24
Effect of bimonthly supplementation with oral cholecalciferol on serum 25-hydroxyvitamin D concentrations in HIV-infected children and adolescents. Pediatrics (2009) 1.22
Fracture incidence in HIV-infected women: results from the Women's Interagency HIV Study. AIDS (2010) 1.19
Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women. J Bone Miner Res (2013) 1.17
Leptin administration does not prevent the bone mineral metabolism changes induced by weight loss. Metabolism (2011) 1.17
Low bone mass and high bone turnover in postmenopausal human immunodeficiency virus-infected women. J Clin Endocrinol Metab (2009) 1.16
Higher rates of bone loss in postmenopausal HIV-infected women: a longitudinal study. J Clin Endocrinol Metab (2011) 1.16
Cohort Profile: the Concord Health and Ageing in Men Project (CHAMP). Int J Epidemiol (2008) 1.15
Three dimensional cancellous bone structure in hypoparathyroidism. Bone (2009) 1.12
Abnormal microarchitecture and stiffness in postmenopausal women with ankle fractures. J Clin Endocrinol Metab (2011) 1.12
Abnormal bone microarchitecture and evidence of osteoblast dysfunction in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab (2011) 1.11
Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy. Ann Neurol (2005) 1.11
Gender differences in plasma ghrelin and its relations to body composition and bone - an opposite-sex twin study. Clin Endocrinol (Oxf) (2007) 1.06
Low bone formation in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab (2005) 1.06
Discriminants of prevalent fractures in chronic kidney disease. J Am Soc Nephrol (2011) 1.05
Multicenter precision of cortical and trabecular bone quality measures assessed by high-resolution peripheral quantitative computed tomography. J Bone Miner Res (2013) 1.02
Evolving data about subtrochanteric fractures and bisphosphonates. N Engl J Med (2010) 1.02
Vitamin D deficiency influences histomorphometric features of bone in primary hyperparathyroidism. Bone (2010) 1.01
Bone material properties in premenopausal women with idiopathic osteoporosis. J Bone Miner Res (2012) 1.00
Prevention of bone loss by zoledronic acid in premenopausal women undergoing adjuvant chemotherapy persist up to one year following discontinuing treatment. J Clin Endocrinol Metab (2009) 0.99
Gender differences in relationships between body composition components, their distribution and bone mineral density: a cross-sectional opposite sex twin study. Osteoporos Int (2005) 0.99
Skeletal structure in postmenopausal women with osteopenia and fractures is characterized by abnormal trabecular plates and cortical thinning. J Bone Miner Res (2014) 0.98
Teriparatide for idiopathic osteoporosis in premenopausal women: a pilot study. J Clin Endocrinol Metab (2013) 0.98
Osteoporosis after solid organ and bone marrow transplantation. Osteoporos Int (2003) 0.97
Prolonged hypocalcemia after treatment with zoledronic acid in a patient with prostate cancer and vitamin D deficiency. J Clin Oncol (2004) 0.96
Increased marrow adiposity in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab (2012) 0.96
Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW). Bone (2011) 0.96
Activated protein C prevents inflammation yet stimulates angiogenesis to promote cutaneous wound healing. Wound Repair Regen (2005) 0.95
Teriparatide increases strength of the peripheral skeleton in premenopausal women with idiopathic osteoporosis: a pilot HR-pQCT study. J Clin Endocrinol Metab (2014) 0.94
Clinical imaging of bone microarchitecture with HR-pQCT. Curr Osteoporos Rep (2013) 0.94
Secondary osteoporosis. Endocrinol Metab Clin North Am (2003) 0.94
Effect of supplementation with cholecalciferol and calcium on 2-y bone mass accrual in HIV-infected children and adolescents: a randomized clinical trial. Am J Clin Nutr (2012) 0.94
Microarchitectural abnormalities are more severe in postmenopausal women with vertebral compared to nonvertebral fractures. J Clin Endocrinol Metab (2012) 0.93
Gender differences in the genetic factors responsible for variation in bone density and ultrasound. J Bone Miner Res (2002) 0.93
Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs. Epilepsy Behav (2003) 0.93
Post-transplantation osteoporosis. Endocrinol Metab Clin North Am (2007) 0.91
Insights from the conduct of a device trial in older persons: low magnitude mechanical stimulation for musculoskeletal health. Clin Trials (2010) 0.90
Lower peak bone mass and abnormal trabecular and cortical microarchitecture in young men infected with HIV early in life. AIDS (2014) 0.90
Osteoporosis after solid organ transplantation. J Clin Endocrinol Metab (2004) 0.90
Idiopathic osteoporosis in premenopausal women. Osteoporos Int (2004) 0.90
Longitudinal HR-pQCT and image registration detects endocortical bone loss in kidney transplantation patients. J Bone Miner Res (2015) 0.89
Site-specific changes in bone microarchitecture, mineralization, and stiffness during lactation and after weaning in mice. J Bone Miner Res (2012) 0.89
Cartilage defects are associated with physical disability in obese adults. Rheumatology (Oxford) (2009) 0.89
Clinical characteristics and medication use among premenopausal women with osteoporosis and low BMD: the experience of an osteoporosis referral center. J Womens Health (Larchmt) (2009) 0.88
Effect of clenbuterol on cardiac and skeletal muscle function during left ventricular assist device support. J Heart Lung Transplant (2006) 0.88
Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk. Cancer Causes Control (2014) 0.86
Gender differences in volumetric bone density: a study of opposite-sex twins. Osteoporos Int (2003) 0.86
Low bone-mineral density in patients with HIV: pathogenesis and clinical significance. Curr Opin Endocrinol Diabetes (2006) 0.85
Central QCT reveals lower volumetric BMD and stiffness in premenopausal women with idiopathic osteoporosis, regardless of fracture history. J Clin Endocrinol Metab (2012) 0.85
Guidelines for the management of postmenopausal osteoporosis for GPs. Aust Fam Physician (2004) 0.84
Fast trabecular bone strength predictions of HR-pQCT and individual trabeculae segmentation-based plate and rod finite element model discriminate postmenopausal vertebral fractures. J Bone Miner Res (2013) 0.84
Treatment of premenopausal women with low bone mineral density. Curr Osteoporos Rep (2008) 0.84
Metabolic bone disease in human immunodeficiency virus-infected children. J Clin Endocrinol Metab (2004) 0.84
Bone quality determined by Fourier transform infrared imaging analysis in mild primary hyperparathyroidism. J Clin Endocrinol Metab (2008) 0.83
Osteoporosis in diffuse parenchymal lung disease. Chest (2006) 0.83
Effect of renal function on skeletal health in primary hyperparathyroidism. J Clin Endocrinol Metab (2012) 0.83
A longitudinal study of knee pain in older men: Concord Health and Ageing in Men Project. Age Ageing (2013) 0.82
Tumour necrosis factor blockade and the risk of osteoporosis: back to the future. Arthritis Res Ther (2007) 0.82
Clinical assessment of the 1/3 radius using a new desktop ultrasonic bone densitometer. Ultrasound Med Biol (2013) 0.82
Severe vitamin D deficiency among heart and liver transplant recipients. Clin Transplant (2009) 0.82
Vitamin D Deficiency Is Prevalent in Morbidly Obese Adolescents Prior to Bariatric Surgery. ISRN Obes (2013) 0.81
Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg (2008) 0.81